epocrates logo
epocrates logo
epocrates logo
  • 0

Drugs


Formulary
No Formulary Selected

Classes

  • All Drugs
  • Allergy/Cold/ENT
  • Anesthesia/Pain Management
  • Asthma/Pulmonary
  • Cardiovascular
  • Dental/Oral Care
  • Dermatologic
  • Diagnostic
  • Emergency
  • Endocrine/Metabolism
  • Gastrointestinal
  • Hematology/Oncology
  • Immunizations
  • Immunology
  • Infectious Disease
  • Nephrology/Urology
  • Neurologic
  • Nutrition/Electrolytes
  • Obstetrics/Gynecology
  • Ophthalmic
  • Psychiatric
  • Rheumatologic

Drug Names

# A B C D E F G H  I  J K L M N O P Q R S T U V W X Y Z
A+D Anti-Chafing Ointment
A+D Diaper Rash Cream
A+D First Aid Ointment
A+D Incontinence Support Skin Protectant & Rash Ointment
A+D Medicated Rash Ointment
A+D Original Ointment
A+D Overnight Healing Rash Ointment
abacavir
abacavir/dolutegravir/lamivudine
abacavir/lamivudine
abacavir/lamivudine/zidovudine
abaloparatide
abametapir topical
abatacept
Abecma
Abelcet
abemaciclib
Abigale
Abigale Lo
Abilify
Abilify Asimtufii
Abilify Discmelt
Abilify Maintena
Abilify MyCite
abiraterone acetate
abiraterone acetate micronized
Ablysinol
abobotulinumtoxinA
Abraxane
Abreva
Abreva Rapid Pain Relief
Abrilada (adalimumab-afzb)
abrocitinib
Abrysvo
Absorica
Absorica LD
Abstral
acalabrutinib
ACAM2000
acamprosate
Acanya
acarbose
Accolate
Accrufer
AccuNeb
Accupril
Accuretic
Accutane
acebutolol
aceclidine ophthalmic
Aceon
Acetadote
acetaminophen
acetaminophen rectal
acetaminophen/aspirin
acetaminophen/aspirin/caffeine
acetaminophen/aspirin/diphenhydramine
acetaminophen/caffeine
acetaminophen/caffeine/dihydrocodeine
acetaminophen/caffeine/pyrilamine
acetaminophen/chlorpheniramine
acetaminophen/chlorpheniramine/dextromethorphan
acetaminophen/chlorpheniramine/dextromethorphan/phenylephrine
acetaminophen/chlorpheniramine/dextromethorphan/pseudoephedrine
acetaminophen/chlorpheniramine/phenylephrine
acetaminophen/codeine
acetaminophen/dextromethorphan
acetaminophen/dextromethorphan/guaifenesin
acetaminophen/dextromethorphan/phenylephrine
acetaminophen/dextromethorphan/phenylephrine/guaifenesin
acetaminophen/dextromethorphan/pseudoephedrine
acetaminophen/diphenhydramine
acetaminophen/diphenhydramine/phenylephrine
acetaminophen/doxylamine/dextromethorphan
acetaminophen/doxylamine/dextromethorphan/phenylephrine
acetaminophen/guaifenesin
acetaminophen/ibuprofen
acetaminophen/pamabrom
acetaminophen/pamabrom/pyrilamine
acetaminophen/phenylephrine
acetaminophen/phenylephrine/guaifenesin
acetaminophen/pseudoephedrine
acetaminophen/triprolidine/dextromethorphan
acetaminophen/triprolidine/dextromethorphan/phenylephrine
acetazolamide
acetic acid otic
acetohydroxamic acid
acetylcholine intraocular
acetylcysteine
Aciphex
Aciphex Sprinkle
acitretin
aclidinium bromide inhaled
aclidinium bromide/formoterol inhaled
Aclovate
acoltremon ophthalmic
acoramidis
acrivastine/pseudoephedrine
Actemra
Acthar Gel
ActHIB
Acticlate
Actidose with Sorbitol
Actidose-Aqua
Actigall
Actimmune
Actiq
Activase
Activella
Actonel
Actonel with Calcium
ACTOplus met
ACTOplus met XR
Actos
Acular
Acular LS
Acuvail
Acuvue Theravision with Ketotifen
acyclovir
acyclovir oropharyngeal
acyclovir topical
acyclovir/hydrocortisone topical
Aczone
Adacel
adagrasib
Adakveo (crizanlizumab-tmca)
Adalat CC
adalimumab
ADAMTS13, recombinant
adapalene topical
adapalene/benzoyl peroxide topical
Adasuve
Adbry (tralokinumab-ldrm)
Adcetris
Adcirca
Adderall
Adderall XR
Addyi
adefovir dipivoxil
Adempas
Adenocard
Adenoscan
adenosine
adenovirus type 4 and type 7 vaccine, live oral
Adhansia XR
Adipex-P
Adlarity
Adlyxin
Admelog
ado-trastuzumab emtansine
Adoxa
Adquey
Adrenaclick
Adrenalin
Adriamycin
Adrucil
Adstiladrin (nadofaragene firadenovec-vncg)
aducanumab
Aduhelm (aducanumab-avwa)
Advair Diskus
Advair HFA
Advate
Advil
Advil Allergy & Congestion Relief
Advil Allergy Sinus
Advil Cold & Sinus
Advil Dual Action with Acetaminophen
Advil Dual Action with Acetaminophen Back Pain
Advil Migraine
Advil Multi-Symptom Cold & Flu
Advil PM
Advil Sinus Congestion & Pain
Advil Targeted Relief Cream
Adynovate
Adzenys ER
Adzenys XR-ODT
Adzynma (ADAMTS13, recombinant-krhn)
Aemcolo
afamelanotide
afamitresgene autoleucel
afatinib
Afeditab CR
aficamten
Afinitor
Afinitor Disperz
aflibercept intravitreal
Afluria
Afrezza
Afrin Allergy Sinus
Afrin No Drip Allergy Sinus
Afrin No Drip Allergy Sinus Night
Afrin No Drip Extra Moisturizing
Afrin No Drip Night
Afrin No Drip Original
Afrin No Drip Severe Congestion
Afrin Original
Afrin Severe Congestion
Afstyla
agalsidase beta
Agamree
Aggrastat
Aggrenox
Agrylin
Ahzantive (aflibercept-mrbb)
Aimovig (erenumab-aooe)
air polymer-type A
AirDuo Digihaler
AirDuo RespiClick
Airsupra
Ajovy (fremanezumab-vfrm)
AK-Dilate
AK-Poly-Bac
Akeega
Aklief
Akne-mycin
Akovaz
Akten
Aktipak
Akynzeo
Akynzeo IV
Ala-hist IR
Alahist CF
Alahist D
Alahist DM
Alahist PE
Alamast
Alavert
Alavert D-12 Hour
Alaway
albendazole
Albenza
albiglutide
Albuked
albumin (human)
Albuminar
Albuminex (albumin (human)-kjda)
AlbuRx
Albutein
albuterol
albuterol inhaled
albuterol/budesonide inhaled
alcaftadine ophthalmic
Alcaine
alclometasone topical
Aldactazide
Aldactone
Aldara
aldesleukin
Aldomet
Aldurazyme
Alecensa
alectinib
alemtuzumab
alendronate
alendronate/cholecalciferol
Alesse
Aleve
Aleve Arthritis Pain Gel
Aleve Back & Muscle Pain
Aleve Headache Pain
Aleve PM
Aleve-D Sinus & Cold
AleveX Lotion
AleveX Spray
Alfenta
alfentanil
alfuzosin
alglucosidase alfa
Alhemo (concizumab-mtci)
Alimta
Alinia
Aliqopa
alirocumab
aliskiren
aliskiren/hydrochlorothiazide
alitretinoin topical
Alka-Seltzer Cool Action Heartburn Relief Gum
Alka-Seltzer Extra Strength Heartburn ReliefChews
Alka-Seltzer Extra Strength Upset Stomach Relief
Alka-Seltzer Hangover Relief
Alka-Seltzer Heartburn + Gas ReliefChews
Alka-Seltzer Original
Alka-Seltzer Plus Cold & Flu FizzyChews
Alka-Seltzer Plus Cough & Sore Throat FizzyChews
Alka-Seltzer Plus Maximum Strength Cold & Cough
Alka-Seltzer Plus Maximum Strength Cold & Cough PowerMax
Alka-Seltzer Plus Maximum Strength Cold & Flu Day
Alka-Seltzer Plus Maximum Strength Cold & Flu Day PowerMax
Alka-Seltzer Plus Maximum Strength Cold & Flu Night
Alka-Seltzer Plus Maximum Strength Cold & Flu Night PowerMax
Alka-Seltzer Plus Maximum Strength Cough & Chest Congestion Power...
Alka-Seltzer Plus Maximum Strength Cough, Mucus & Congestion Powe...
Alka-Seltzer Plus Maximum Strength Cough, Mucus & Congestion Powe...
Alka-Seltzer Plus Maximum Strength Sinus Congestion & Pain PowerF...
Alka-Seltzer Plus Maximum Strength Sinus Congestion & Pain PowerM...
Alka-Seltzer Plus Maximum Strength Sinus, Allergy & Cough PowerMa...
Alka-Seltzer Plus Severe Cold & Cough PowerFast Fizz
Alka-Seltzer Plus Severe Cold & Flu Day
Alka-Seltzer Plus Severe Cold & Flu Night
Alka-Seltzer Plus Severe Cold & Flu PowerFast Fizz
Alka-Seltzer Plus Severe Cold PowerFast Fizz
Alka-Seltzer Plus Severe Cold PowerFast Fizz Night
Alka-Seltzer Plus Severe Cold PowerFast Fizz Non-Drowsy
Alka-Seltzer Plus Severe Sinus, Cold & Cough
Alka-Seltzer Upset Stomach Relief
Alkeran
Alkindi Sprinkle
Allegra Allergy 12 Hour
Allegra Allergy 24 Hour
Allegra Hives 24 Hour
Allegra-D 12 Hour Allergy & Congestion
Allegra-D 24 Hour Allergy & Congestion
Aller-chlor
Alli
allogeneic cell therapy
allopurinol
Allzital
almotriptan
Alocril
alogliptin
alogliptin/metformin
alogliptin/pioglitazone
Alomide
Aloprim
Alora
alosetron
Aloxi
alpelisib
alpha-tocopherol (vitamin E)
alpha1-proteinase inhibitor
Alphagan P
Alphanate
alprazolam
Alprolix
alprostadil
alprostadil intracavernous
alprostadil intraurethral
Alrex
Alsuma
Altabax
Altace
Altafluor Benox
Altavera
alteplase
alteplase intracatheter
Altoprev
Altreno
Altuviiio (antihemophilic factor (recombinant), Fc-VWF-XTEN fusio...
aluminum acetate topical (modified Burow's solution)
aluminum chloride topical
aluminum hydroxide
aluminum hydroxide/magnesium carbonate
aluminum hydroxide/magnesium hydroxide
aluminum hydroxide/magnesium hydroxide/simethicone
Alunbrig
Alvaiz
Alvesco
alvimopan
Alyacen 1/35
Alyacen 7/7/7
Alyftrek
Alyglo (immune globulin human-stwk)
Alymsys (bevacizumab-maly)
Alyq
Amabelz
amantadine
Amaryl
Ambien
Ambien CR
AmBisome
ambrisentan
amcinonide topical
Ameluz
Amerge
Amethia
Amethia Lo
Amethyst
Amicar
Amidate
amifampridine
amifostine
amikacin
amikacin liposomal inhaled
Amikin
amiloride
amiloride/hydrochlorothiazide
aminocaproic acid
aminolevulinic acid topical
aminophylline
amiodarone
amisulpride
Amitiza
amitriptyline
amivantamab
amivantamab/hyaluronidase
Amjevita (adalimumab-atto)
amlodipine
amlodipine/atorvastatin
amlodipine/benazepril
amlodipine/celecoxib
amlodipine/olmesartan medoxomil
amlodipine/valsartan
amlodipine/valsartan/hydrochlorothiazide
ammonium lactate topical
Ammonul
Amnesteem
Amondys 45
amoxapine
amoxicillin
amoxicillin/clavulanate
Amoxil
Amphadase
amphetamine
Amphocin
Amphojel
Amphotec
amphotericin B cholesteryl sulfate
amphotericin B deoxycholate
amphotericin B lipid complex
amphotericin B liposomal
ampicillin
ampicillin/sulbactam
Ampyra
Amrix
Amtagvi
Amvuttra
amyl nitrite/sodium nitrite/sodium thiosulfate
Amzeeq
anacaulase topical
Anacin
Anafranil
anagrelide
anakinra
Analpram E
Analpram HC
AnaMantle HC
Anaphylm
Anaprox
Anaprox DS
Anascorp
Anaspaz
anastrozole
Anavip
Anbesol Maximum Strength
Ancef
Ancobon
Andembry (garadacimab-gxii)
Andexxa (coagulation factor Xa (recombinant), inactivated-zhzo)
Androderm
AndroGel
Android
Androxy
Anectine
Angeliq
Angiomax
Angiomax RTU
angiotensin II
anidulafungin
anifrolumab
Anjeso
Anktiva (nogapendekin alfa inbakicept-pmln)
Annovera
Anoro Ellipta
Ansaid
ansuvimab
Antabuse
Antara
Anthim
Anthrasil
anthrax immune globulin (human)
anthrax vaccine
anthrax vaccine, adjuvanted
anti-inhibitor coagulant complex
anti-thymocyte globulin (rabbit)
antihemophilic factor (factor VIII, human)
antihemophilic factor (factor VIII, human)/von Willebrand factor ...
antihemophilic factor (factor VIII, recombinant)
antihemophilic factor (factor VIII, recombinant), Fc fusion prote...
antihemophilic factor (factor VIII, recombinant), glycopegylated
antihemophilic factor (factor VIII, recombinant), pegylated
antihemophilic factor (factor VIII, recombinant), porcine
antihemophilic factor (factor VIII, recombinant), single chain
antihemophilic factor (recombinant), Fc-VWF-XTEN fusion protein
antipyrine/benzocaine otic
antithrombin (recombinant)
antithrombin III
Antivert
Antizol
Anucort-HC
Anusol-HC Cream
Anusol-HC Suppository
Anzupgo
Apadaz
apalutamide
ApexiCon
ApexiCon E
Aphexda
Apidra
apitegromab
Apitegromab
apixaban
Aplenzin
Aplisol
Apokyn
apomorphine
Aponvie
apraclonidine ophthalmic
apremilast
aprepitant
Apresoline
Apretude
Apri
Apriso
aprocitentan
Aptensio XR
Aptiom
Aptivus
Aqneursa
Aquaphor
Aquaphor Baby Diaper Rash
Aquaphor Itch Relief
Aquasol A
Aquasol E
Aqvesme
Arakoda
Aralast NP
Aralen
Aranelle
Aranesp
Arava
Arazlo
Arbinoxa
Arbli
Arcalyst
Aredia
Arepanrix
Arexvy
arformoterol inhaled
argatroban
arginine
Aricept
Aricept ODT
Arikayce
Arimidex
arimoclomol
aripiprazole
aripiprazole bimonthly injection
aripiprazole lauroxil
aripiprazole monthly injection
Aristada
Aristada Initio
Arixtra
Armlupeg (pegfilgrastim-unne)
armodafinil
ArmonAir Digihaler
ArmonAir RespiClick
Armour Thyroid
Arnuity Ellipta
Aromasin
Arranon
arsenic trioxide
Artane
artemether/lumefantrine
artesunate
Arthriten
Arthritis Hot
Arthrotec
articaine/epinephrine
Arymo ER
Arynta
Arzerra
Asacol
Asacol HD
Asceniv (immune globulin human-slra)
asciminib
Ascor
ascorbic acid (vitamin C)
asenapine
asenapine transdermal
asfotase alfa
Ashlyna
Asmanex HFA
Asmanex Twisthaler
asparaginase
asparaginase Erwinia chrysanthemi
asparaginase erwinia chrysanthemi (recombinant)
Asparlas (calaspargase pegol-mknl)
Aspercreme
Aspercreme Arthritis Pain
Aspercreme Lidocaine 3 in 1 Foot Pain Relief Cream
Aspercreme Lidocaine Foot Pain Cream for Diabetic Skin
Aspercreme Lidocaine Pain Relief Cream
Aspercreme Lidocaine Pain Relief Liquid Roll-On
Aspercreme Lidocaine Pain Relief Patch
Aspercreme Lidocaine Pain Relief Spray
aspirin
aspirin/caffeine
aspirin/chlorpheniramine/dextromethorphan/phenylephrine
aspirin/chlorpheniramine/phenylephrine
aspirin/dextromethorphan/phenylephrine
aspirin/dipyridamole
aspirin/omeprazole
Aspruzyo Sprinkle
Astagraf XL
Astelin
Astepro Allergy
Asthmanefrin
Atacand
Atacand HCT
atacicept
Atacicept
Atarax
atazanavir
atazanavir/cobicistat
Atelvia
atenolol
atenolol/chlorthalidone
atezolizumab
atezolizumab/hyaluronidase
Atgam
atidarsagene autotemcel
Ativan
Atmeksi
atogepant
atoltivimab/maftivimab/odesivimab
atomoxetine
Atoncy
Atorvaliq
atorvastatin
atovaquone
atovaquone/proguanil
atracurium
Atralin
atrasentan
Atripla
AtroPen
atropine
atropine ophthalmic
atropine/pralidoxime
Atrovent HFA
Atrovent Nasal
ATryn
Attruby
Atzumi
Aubagio
Aubra EQ
Aucatzyl
Audenz
Augmentin
Augmentin ES-600
Augmentin XR
Augtyro
Aukelso (denosumab-kyqq)
Auralgan (original formulation)
auranofin
Aurlumyn
Aurovela 1.5/30
Aurovela 1/20
Aurovela 24 Fe
Aurovela Fe 1.5/30
Aurovela Fe 1/20
Auryxia
Austedo
Austedo XR
autologous mesenchymal stem cell-neurotrophic factor (MSC-NTF) ce...
Auvelity
Auvi-Q
avacincaptad pegol intravitreal
avacopan
Avage
avalglucosidase alfa
Avalide
avanafil
Avandaryl
Avandia
avapritinib
Avapro
avasopasem
Avasopasem
Avastin
avatrombopag
Aveed
Aveeno Anti-Itch Concentrated Lotion
Aveeno Baby Calming Comfort Lotion
Aveeno Baby Daily Moisture Cream
Aveeno Baby Daily Moisture Lotion
Aveeno Baby Eczema Therapy Moisturizing Cream
Aveeno Baby Eczema Therapy Nighttime Balm
Aveeno Baby Eczema Therapy Soothing Bath Treatment
Aveeno Calm + Restore Skin Therapy Balm
Aveeno Daily Moisturizing Lotion
Aveeno Eczema Therapy Moisturizing Cream
Aveeno Eczema Therapy Nighttime Itch Relief Balm
Aveeno Eczema Therapy Rescue Relief Treatment Gel Cream
Aveeno Hydrocortisone Anti-Itch Cream
Aveeno Positively Radiant Clear Complexion
Aveeno Skin Relief Hand Cream
Aveeno Skin Relief Moisturizing Lotion
Aveeno Skin Relief Overnight Cream
Aveeno Soothing Bath Treatment
Avelox
avelumab
Averi
Avgemsi
Aviane
Avidoxy
Avinza
Avita
Avlayah (tividenofusp alfa-eknm)
Avmapki Fakzynja Co-Pack
Avodart
Avonex
Avopef
Avsola (infliximab-axxq)
Avtozma (tocilizumab-anoh)
avutometinib and defactinib
Avycaz
Avzivi (bevacizumab-tnjn)
Awiqli (insulin icodec-abae)
axatilimab
Axert
axicabtagene ciloleucel
Axid
Axiron
axitinib
Axtle
Aygestin
Ayvakit
azacitidine
Azactam
Azasan
AzaSite
azathioprine
Azedra
azelaic acid topical
azelastine nasal
azelastine ophthalmic
azelastine/fluticasone propionate nasal
Azelex
Azilect
azilsartan medoxomil
azilsartan medoxomil/chlorthalidone
azithromycin
azithromycin ophthalmic
Azmacort
Azmiro
Azo Urinary Pain Relief
Azo Urinary Pain Relief Maximum Strength
Azopt
Azor
Azstarys
aztreonam
aztreonam inhaled
aztreonam/avibactam
Azulfidine
Azulfidine EN-tabs
Azurette

close

 

Select a medication above to begin.

Yuvezzi

carbachol/ brimonidine ophthalmic

Drug Monograph

  • Black Box Warnings
  • Adult Dosing
  • Peds Dosing
  • Contraindications/Cautions
  • Drug Interactions
  • Adverse Reactions
  • Safety/Monitoring
  • Pregnancy/Lactation
  • Pharmacology
  • Formulary
  • Manufacturer/Pricing
  • Patient Education
  • Pill Pictures
  • Add to Interaction Check
  • Dosing Calculator

Adult Dosing .

Dosage forms:  SOLUTION: 2.75%/0.1%

presbyopia

[1 drop in eye(s) qd]

Peds Dosing .

Peds dosing is currently unavailable or not applicable for this drug.

Contraindications / Cautions .

    com.epocrates.rxweb.beans.StringCollection@7c9c4df0
  • hypersensitivity to drug or ingredient
  • iritis
  • caution: retinal disorder
  • caution: depression
  • caution: cerebral insufficiency
  • caution: coronary insufficiency
  • caution: Raynaud phenomenon
  • caution: hypotension, orthostatic
  • caution: thromboangiitis obliterans
  • caution: CNS depressant use, concurrent

Drug Interactions .

Overview

brimonidine ophthalmic

alpha-2 agonist ophthalmic

Interaction Characteristics:
  • CNS depression
  • hypotensive effects

carbachol ophthalmic

cholinergic agent

Interaction Characteristics:
  • cholinergic effects
  • miosis agent

Avoid/Use Alternative

  • apraclonidine ophthalmic
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    apraclonidine ophthalmic
    1 interaction

    Avoid/Use Alternative

    brimonidine ophthalmic + apraclonidine ophthalmic

    avoid combo: combo may increase risk of hypotension, CNS depression, psychomotor impairment, other adverse effects (additive effects, duplicate therapy)

  • butalbital
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    butalbital
    1 interaction

    Avoid/Use Alternative

    brimonidine ophthalmic + butalbital

    avoid combo if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS and respiratory depression, psychomotor impairment (additive effects)

  • clonidine
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    clonidine
    1 interaction

    Avoid/Use Alternative

    brimonidine ophthalmic + clonidine

    if ADHD use, avoid combo; otherwise, monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment, hypotension, including orthostasis (additive effects)

  • codeine
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    codeine
    1 interaction

    Avoid/Use Alternative

    brimonidine ophthalmic + codeine

    avoid combo if antitussive use; otherwise, if elevated IOP or presbyopia use monitor BP, respiratory rate; decrease dose of one or both drugs, use lowest effective doses and shortest duration of concomitant treatment; OTC ocular redness use OK: combo may increase risk of profound CNS and respiratory depression, psychomotor impairment, severe hypotension, including orthostasis, syncope (additive effects)

  • doxylamine
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    doxylamine
    1 interaction

    Avoid/Use Alternative

    brimonidine ophthalmic + doxylamine

    avoid combo if doxylamine use for pregnancy-related nausea/vomiting; otherwise, caution advised if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment (additive effects)

  • ethanol (alcoholic beverage)
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    ethanol (alcoholic beverage)
    1 interaction

    Avoid/Use Alternative

    brimonidine ophthalmic + ethanol (alcoholic beverage)

    avoid combo if brimonidine elevated IOP or presbyopia use; OTC ocular redness use OK: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment, severe hypotension (additive effects)

  • ethanol injection
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    ethanol injection
    1 interaction

    Avoid/Use Alternative

    brimonidine ophthalmic + ethanol injection

    use alternative or monitor respiratory rate, BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment, severe hypotension (additive effects)

  • hydrocodone
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    hydrocodone
    1 interaction

    Avoid/Use Alternative

    brimonidine ophthalmic + hydrocodone

    avoid combo if antitussive use; otherwise, if elevated IOP or presbyopia use monitor BP, respiratory rate; decrease dose of one or both drugs, use lowest effective doses and shortest duration of concomitant treatment; OTC ocular redness use OK: combo may increase risk of profound CNS and respiratory depression, psychomotor impairment, severe hypotension, including orthostasis, syncope (additive effects)

  • isocarboxazid
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    isocarboxazid
    1 interaction

    Avoid/Use Alternative

    brimonidine ophthalmic + isocarboxazid

    if brimonidine elevated IOP or presbyopia use, use alternative during and x10 days after isocarboxazid use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment, hypotension, including orthostasis; may interfere with IOP lowering effect of brimonidine ophthalmic (additive effects; antagonistic effects)

  • kratom
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    kratom
    1 interaction

    Avoid/Use Alternative

    brimonidine ophthalmic + kratom

    use alternative or monitor respiratory rate if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of profound CNS and respiratory depression, psychomotor impairment (additive effects)

  • metaxalone
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    metaxalone
    1 interaction

    Avoid/Use Alternative

    brimonidine ophthalmic + metaxalone

    use alternative or monitor respiratory rate if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS and respiratory depression, psychomotor impairment (additive effects)

  • metoclopramide
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    metoclopramide
    1 interaction

    Avoid/Use Alternative

    brimonidine ophthalmic + metoclopramide

    use alternative if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment (additive effects)

  • midazolam
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    midazolam
    1 interaction

    Avoid/Use Alternative

    brimonidine ophthalmic + midazolam

    use alternative or monitor BP, respiratory rate if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of profound CNS and respiratory depression, psychomotor impairment, hypotension (additive effects)

  • phenelzine
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    phenelzine
    1 interaction

    Avoid/Use Alternative

    brimonidine ophthalmic + phenelzine

    use alternative or monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment, hypotension, including orthostasis; may interfere with IOP lowering effect of brimonidine ophthalmic (additive effects; antagonistic effects)

  • promethazine
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    promethazine
    1 interaction

    Avoid/Use Alternative

    brimonidine ophthalmic + promethazine

    use alternative or if elevated IOP or presbyopia use, monitor BP, respiratory rate; decrease dose of one or both drugs; OTC ocular redness use OK: combo may increase risk of CNS and respiratory depression, psychomotor impairment, hypotension (additive effects)

  • ropeginterferon alfa-2b
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    ropeginterferon alfa-2b
    1 interaction

    Avoid/Use Alternative

    brimonidine ophthalmic + ropeginterferon alfa-2b

    use alternative if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment (additive effects)

  • scopolamine
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    scopolamine
    1 interaction

    Avoid/Use Alternative

    brimonidine ophthalmic + scopolamine

    use alternative if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment (additive effects)

  • tradipitant
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    tradipitant
    1 interaction

    Avoid/Use Alternative

    brimonidine ophthalmic + tradipitant

    use alternative if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment (additive effects)

  • tranylcypromine
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    tranylcypromine
    1 interaction

    Avoid/Use Alternative

    brimonidine ophthalmic + tranylcypromine

    use alternative or monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment, hypotension, including orthostasis; may interfere with IOP lowering effect of brimonidine ophthalmic (additive effects; antagonistic effects)

Monitor/Modify Tx

  • acebutolol
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    acebutolol
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + acebutolol

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of hypotension (additive effects)

  • aldesleukin
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    aldesleukin
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + aldesleukin

    monitor BP if elevated IOP or presbyopia use; withhold aldesleukin if moderate to severe somnolence occurs; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment, severe or life-threatening hypotension (additive effects)

  • alfentanil
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    alfentanil
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + alfentanil

    if elevated IOP or presbyopia use, monitor BP, respiratory rate; decrease dose of one or both drugs; OTC ocular redness use OK: combo may increase risk of profound CNS and respiratory depression, psychomotor impairment, severe hypotension, including orthostasis, syncope (additive effects)

  • alfuzosin
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    alfuzosin
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + alfuzosin

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of hypotension, including orthostasis, syncope (additive effects)

  • aliskiren
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    aliskiren
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + aliskiren

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of hypotension (additive effects)

  • alprostadil intracavernous
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    alprostadil intracavernous
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + alprostadil intracavernous

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of hypotension (additive effects)

  • amantadine
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    amantadine
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + amantadine

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment, hypotension, including orthostasis, syncope (additive effects)

  • amifostine
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    amifostine
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + amifostine

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of severe hypotension, including syncope (additive effects)

  • amiloride
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    amiloride
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + amiloride

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of hypotension (additive effects)

  • amitriptyline
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    amitriptyline
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + amitriptyline

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment, hypotension, including orthostasis; may interfere with IOP lowering effect of brimonidine ophthalmic (additive effects; antagonistic effects)

  • amlodipine
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    amlodipine
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + amlodipine

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of hypotension (additive effects)

  • amoxapine
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    amoxapine
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + amoxapine

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment, hypotension, including orthostasis; may interfere with IOP lowering effect of brimonidine ophthalmic (additive effects; antagonistic effects)

  • apomorphine
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    apomorphine
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + apomorphine

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment, severe hypotension, including orthostasis, syncope (additive effects)

  • aprocitentan
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    aprocitentan
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + aprocitentan

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of hypotension (additive effects)

  • aripiprazole bimonthly injection
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    aripiprazole bimonthly injection
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + aripiprazole bimonthly injection

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment, hypotension, including orthostasis, syncope (additive effects)

  • aripiprazole lauroxil
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    aripiprazole lauroxil
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + aripiprazole lauroxil

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment, hypotension, including orthostasis (additive effects)

  • aripiprazole monthly injection
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    aripiprazole monthly injection
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + aripiprazole monthly injection

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment, hypotension, including orthostasis (additive effects)

  • aripiprazole oral
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    aripiprazole oral
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + aripiprazole oral

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment, hypotension, including orthostasis (additive effects)

  • articaine
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    articaine
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + articaine

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of hypotension (additive effects)

  • asenapine
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    asenapine
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + asenapine

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment, hypotension, including orthostasis, syncope (additive effects)

  • atenolol
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    atenolol
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + atenolol

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of hypotension (additive effects)

  • avanafil
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    avanafil
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + avanafil

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of hypotension, including orthostasis, syncope (additive effects)

  • azilsartan medoxomil
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    azilsartan medoxomil
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + azilsartan medoxomil

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of hypotension (additive effects)

  • benazepril
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    benazepril
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + benazepril

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of hypotension (additive effects)

  • berberine
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    berberine
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + berberine

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of hypotension (additive effects)

  • betaxolol
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    betaxolol
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + betaxolol

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of hypotension (additive effects)

  • betaxolol ophthalmic
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    betaxolol ophthalmic
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + betaxolol ophthalmic

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of hypotension (additive effects)

  • bethanechol
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    bethanechol
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + bethanechol

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of hypotension (additive effects)

  • bexagliflozin
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    bexagliflozin
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + bexagliflozin

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of hypotension, including orthostasis (additive effects)

  • bisoprolol
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    bisoprolol
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + bisoprolol

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of hypotension (additive effects)

  • bortezomib
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    bortezomib
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + bortezomib

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of severe hypotension, including orthostasis, syncope (additive effects)

  • brexpiprazole
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    brexpiprazole
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + brexpiprazole

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment, hypotension, including orthostasis, syncope (additive effects)

  • brimonidine topical
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    brimonidine topical
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + brimonidine topical

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment, hypotension, including orthostasis (additive effects)

  • bromocriptine
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    bromocriptine
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + bromocriptine

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment, hypotension, including orthostasis, syncope (additive effects)

  • bumetanide
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    bumetanide
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + bumetanide

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of hypotension (additive effects)

  • bupivacaine
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    bupivacaine
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + bupivacaine

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of hypotension (additive effects)

  • bupivacaine liposomal
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    bupivacaine liposomal
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + bupivacaine liposomal

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of hypotension (additive effects)

  • buprenorphine
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    buprenorphine
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + buprenorphine

    if elevated IOP or presbyopia use, monitor BP, respiratory rate; decrease dose of one or both drugs, use lowest effective doses and shortest duration of concomitant treatment; OTC ocular redness use OK: combo may increase risk of profound CNS and respiratory depression, psychomotor impairment, severe hypotension, including orthostasis, syncope (additive effects)

  • butorphanol
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    butorphanol
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + butorphanol

    if elevated IOP or presbyopia use, monitor BP, respiratory rate; decrease dose of one or both drugs, use lowest effective doses and shortest duration of concomitant treatment; OTC ocular redness use OK: combo may increase risk of profound CNS and respiratory depression, psychomotor impairment, hypotension, including syncope (additive effects)

  • cabergoline
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    cabergoline
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + cabergoline

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of hypotension, including orthostasis, syncope (additive effects)

  • canagliflozin
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    canagliflozin
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + canagliflozin

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of hypotension, including orthostasis, syncope (additive effects)

  • candesartan cilexetil
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    candesartan cilexetil
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + candesartan cilexetil

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of hypotension (additive effects)

  • cannabis
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    cannabis
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + cannabis

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment, hypotension, including orthostasis (additive effects)

  • captopril
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    captopril
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + captopril

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of hypotension (additive effects)

  • carbamazepine
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    carbamazepine
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + carbamazepine

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment, hypotension, including syncope (additive effects)

  • cariprazine
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    cariprazine
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + cariprazine

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment, hypotension, including orthostasis, syncope (additive effects)

  • carteolol ophthalmic
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    carteolol ophthalmic
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + carteolol ophthalmic

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of hypotension (additive effects)

  • carvedilol
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    carvedilol
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + carvedilol

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of hypotension (additive effects)

  • chloroprocaine
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    chloroprocaine
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + chloroprocaine

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of hypotension (additive effects)

  • chlorothiazide
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    chlorothiazide
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + chlorothiazide

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of hypotension (additive effects)

  • chlorpromazine
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    chlorpromazine
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + chlorpromazine

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment, hypotension, including orthostasis, syncope (additive effects)

  • chlorthalidone
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    chlorthalidone
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + chlorthalidone

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of hypotension (additive effects)

  • cilostazol
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    cilostazol
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + cilostazol

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of hypotension (additive effects)

  • clevidipine
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    clevidipine
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + clevidipine

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of hypotension (additive effects)

  • clofarabine
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    clofarabine
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + clofarabine

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of severe hypotension (additive effects)

  • clomipramine
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    clomipramine
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + clomipramine

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment, hypotension, including orthostasis; may interfere with IOP lowering effect of brimonidine ophthalmic (additive effects; antagonistic effects)

  • clozapine
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    clozapine
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + clozapine

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment, hypotension, including orthostasis, syncope (additive effects)

  • coenzyme Q-10
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    coenzyme Q-10
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + coenzyme Q-10

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of hypotension (additive effects)

  • dapagliflozin
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    dapagliflozin
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + dapagliflozin

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of hypotension, including orthostasis (additive effects)

  • denileukin diftitox
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    denileukin diftitox
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + denileukin diftitox

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of hypotension, including orthostasis (additive effects)

  • desflurane
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    desflurane
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + desflurane

    monitor BP, respiratory rate if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS and respiratory depression, psychomotor impairment, hypotension (additive effects)

  • desipramine
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    desipramine
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + desipramine

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment, hypotension, including orthostasis; may interfere with IOP lowering effect of brimonidine ophthalmic (additive effects; antagonistic effects)

  • dexmedetomidine
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    dexmedetomidine
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + dexmedetomidine

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment, hypotension, including orthostasis, syncope (additive effects)

  • dexmedetomidine injection
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    dexmedetomidine injection
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + dexmedetomidine injection

    monitor BP, respiratory rate if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS and respiratory depression, psychomotor impairment, severe or life-threatening hypotension (additive effects)

  • dihydrocodeine
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    dihydrocodeine
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + dihydrocodeine

    if elevated IOP or presbyopia use, monitor BP, respiratory rate; decrease dose of one or both drugs, use lowest effective doses and shortest duration of concomitant treatment; OTC ocular redness use OK: combo may increase risk of profound CNS and respiratory depression, psychomotor impairment, severe hypotension, including orthostasis, syncope (additive effects)

  • diltiazem
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    diltiazem
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + diltiazem

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of hypotension (additive effects)

  • dinutuximab
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    dinutuximab
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + dinutuximab

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of severe hypotension (additive effects)

  • dipyridamole
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    dipyridamole
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + dipyridamole

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of severe hypotension (additive effects)

  • doxazosin
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    doxazosin
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + doxazosin

    monitor BP if elevated IOP or presbyopia use, especially during doxazosin initiation/titration; OTC ocular redness use OK: combo may increase risk of hypotension, including orthostasis, syncope (additive effects)

  • doxepin
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    doxepin
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + doxepin

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment, hypotension, including orthostasis; may interfere with IOP lowering effect of brimonidine ophthalmic (additive effects; antagonistic effects)

  • dronabinol
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    dronabinol
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + dronabinol

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment, hypotension, including orthostasis (additive effects)

  • duloxetine
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    duloxetine
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + duloxetine

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment, hypotension, including orthostasis (additive effects)

  • empagliflozin
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    empagliflozin
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + empagliflozin

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of hypotension, including orthostasis (additive effects)

  • enalapril
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    enalapril
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + enalapril

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of hypotension (additive effects)

  • enalaprilat
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    enalaprilat
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + enalaprilat

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of hypotension (additive effects)

  • entacapone
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    entacapone
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + entacapone

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment, hypotension, including orthostasis, syncope (additive effects)

  • entrectinib
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    entrectinib
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + entrectinib

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment, hypotension (additive effects)

  • eplerenone
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    eplerenone
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + eplerenone

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of hypotension (additive effects)

  • epoprostenol
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    epoprostenol
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + epoprostenol

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of severe hypotension (additive effects)

  • ertugliflozin
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    ertugliflozin
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + ertugliflozin

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of hypotension, including orthostasis (additive effects)

  • esketamine
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    esketamine
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + esketamine

    monitor respiratory rate if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS and respiratory depression, psychomotor impairment (additive effects)

  • esmolol
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    esmolol
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + esmolol

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of hypotension (additive effects)

  • ethacrynic acid
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    ethacrynic acid
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + ethacrynic acid

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of hypotension (additive effects)

  • ethanol (in some formulations)
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    ethanol (in some formulations)
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + ethanol (in some formulations)

    monitor respiratory rate if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS and respiratory depression, psychomotor impairment (additive effects)

  • etomidate
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    etomidate
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + etomidate

    monitor respiratory rate if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS and respiratory depression, psychomotor impairment (additive effects)

  • etripamil nasal
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    etripamil nasal
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + etripamil nasal

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of hypotension, including syncope (additive effects)

  • felodipine
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    felodipine
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + felodipine

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of hypotension (additive effects)

  • fenoldopam
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    fenoldopam
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + fenoldopam

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of hypotension (additive effects)

  • fentanyl
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    fentanyl
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + fentanyl

    if elevated IOP or presbyopia use, monitor BP, respiratory rate; decrease dose of one or both drugs, use lowest effective doses and shortest duration of concomitant treatment; OTC ocular redness use OK: combo may increase risk of profound CNS and respiratory depression, psychomotor impairment, severe hypotension, including orthostasis, syncope (additive effects)

  • ferumoxytol
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    ferumoxytol
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + ferumoxytol

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of hypotension (additive effects)

  • flaxseed
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    flaxseed
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + flaxseed

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of hypotension (additive effects)

  • flibanserin
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    flibanserin
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + flibanserin

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment, severe hypotension, including syncope (additive effects)

  • fluphenazine
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    fluphenazine
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + fluphenazine

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment, hypotension, including orthostasis (additive effects)

  • fosinopril
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    fosinopril
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + fosinopril

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of hypotension (additive effects)

  • foslevodopa
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    foslevodopa
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + foslevodopa

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment, hypotension, including orthostasis, syncope (additive effects)

  • furosemide
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    furosemide
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + furosemide

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of hypotension (additive effects)

  • garlic
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    garlic
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + garlic

    if brimonidine elevated IOP or presbyopia use, monitor BP with supplemental garlic; otherwise, dietary garlic intake, brimonidine OTC ocular redness use OK: combo may increase risk of hypotension (additive effects)

  • gilteritinib
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    gilteritinib
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + gilteritinib

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of hypotension (additive effects)

  • guanfacine
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    guanfacine
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + guanfacine

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment, hypotension, including orthostasis (additive effects)

  • haloperidol
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    haloperidol
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + haloperidol

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment, hypotension, including orthostasis (additive effects)

  • hydralazine
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    hydralazine
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + hydralazine

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of hypotension (additive effects)

  • hydrochlorothiazide
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    hydrochlorothiazide
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + hydrochlorothiazide

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of hypotension (additive effects)

  • hydromorphone
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    hydromorphone
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + hydromorphone

    if elevated IOP or presbyopia use, monitor BP, respiratory rate; decrease dose of one or both drugs, use lowest effective doses and shortest duration of concomitant treatment; OTC ocular redness use OK: combo may increase risk of profound CNS and respiratory depression, psychomotor impairment, severe hypotension, including orthostasis, syncope (additive effects)

  • ifosfamide
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    ifosfamide
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + ifosfamide

    discontinue one or both drugs if encephalopathy occurs; otherwise, caution advised if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment (additive effects)

  • iloperidone
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    iloperidone
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + iloperidone

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment, hypotension, including orthostasis, syncope (additive effects)

  • iloprost
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    iloprost
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + iloprost

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of severe hypotension, including orthostasis (additive effects)

  • imipramine
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    imipramine
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + imipramine

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment, hypotension, including orthostasis; may interfere with IOP lowering effect of brimonidine ophthalmic (additive effects; antagonistic effects)

  • indapamide
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    indapamide
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + indapamide

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of hypotension, including orthostasis (additive effects)

  • irbesartan
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    irbesartan
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + irbesartan

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of hypotension (additive effects)

  • iron sucrose
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    iron sucrose
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + iron sucrose

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of hypotension (additive effects)

  • isoflurane
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    isoflurane
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + isoflurane

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of profound CNS and respiratory depression, psychomotor impairment, hypotension (additive effects)

  • isosorbide dinitrate
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    isosorbide dinitrate
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + isosorbide dinitrate

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of severe hypotension, including syncope (additive effects)

  • isosorbide mononitrate
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    isosorbide mononitrate
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + isosorbide mononitrate

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of severe hypotension, including syncope (additive effects)

  • isradipine
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    isradipine
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + isradipine

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of hypotension (additive effects)

  • ketamine
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    ketamine
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + ketamine

    if elevated IOP or presbyopia use, monitor respiratory rate; use lowest effective doses and shortest duration of concomitant treatment; OTC ocular redness use OK: combo may increase risk of profound CNS and respiratory depression (including life-threatening), psychomotor impairment (additive effects)

  • labetalol
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    labetalol
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + labetalol

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of hypotension (additive effects)

  • landiolol
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    landiolol
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + landiolol

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of hypotension (additive effects)

  • levobunolol ophthalmic
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    levobunolol ophthalmic
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + levobunolol ophthalmic

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of hypotension (additive effects)

  • levodopa
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    levodopa
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + levodopa

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment, hypotension, including orthostasis, syncope (additive effects)

  • levorphanol
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    levorphanol
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + levorphanol

    if elevated IOP or presbyopia use, monitor BP, respiratory rate; decrease dose of one or both drugs, use lowest effective doses and shortest duration of concomitant treatment; OTC ocular redness use OK: combo may increase risk of profound CNS and respiratory depression, psychomotor impairment, severe hypotension, including orthostasis, syncope (additive effects)

  • lidocaine
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    lidocaine
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + lidocaine

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of hypotension (additive effects)

  • lisinopril
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    lisinopril
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + lisinopril

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of hypotension (additive effects)

  • lofexidine
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    lofexidine
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + lofexidine

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment, hypotension, including orthostasis, syncope (additive effects)

  • losartan
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    losartan
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + losartan

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of hypotension (additive effects)

  • loxapine
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    loxapine
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + loxapine

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment, hypotension, including orthostasis, syncope (additive effects)

  • lubiprostone
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    lubiprostone
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + lubiprostone

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of hypotension, including syncope (additive effects)

  • lumateperone
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    lumateperone
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + lumateperone

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment, hypotension, including orthostasis, syncope (additive effects)

  • lurasidone
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    lurasidone
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + lurasidone

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment, hypotension, including orthostasis, syncope (additive effects)

  • magnesium sulfate
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    magnesium sulfate
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + magnesium sulfate

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of hypotension (additive effects)

  • maraviroc
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    maraviroc
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + maraviroc

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of hypotension, including orthostasis (additive effects)

  • meperidine
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    meperidine
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + meperidine

    if elevated IOP or presbyopia use, monitor BP, respiratory rate; decrease dose of one or both drugs, use lowest effective doses and shortest duration of concomitant treatment; OTC ocular redness use OK: combo may increase risk of profound CNS and respiratory depression, psychomotor impairment, severe hypotension, including orthostasis, syncope (additive effects)

  • mepivacaine
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    mepivacaine
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + mepivacaine

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of hypotension (additive effects)

  • methadone
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    methadone
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + methadone

    if elevated IOP or presbyopia use, monitor BP, respiratory rate; decrease dose of one or both drugs, use lowest effective doses and shortest duration of concomitant treatment; OTC ocular redness use OK: combo may increase risk of profound CNS and respiratory depression, psychomotor impairment, severe hypotension, including orthostasis, syncope (additive effects)

  • methohexital
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    methohexital
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + methohexital

    monitor BP, respiratory rate if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS and respiratory depression, psychomotor impairment, hypotension (additive effects)

  • methyldopa
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    methyldopa
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + methyldopa

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment, hypotension, including orthostasis (additive effects)

  • methylene blue injection
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    methylene blue injection
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + methylene blue injection

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of hypotension, including orthostasis (additive effects)

  • metolazone
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    metolazone
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + metolazone

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of hypotension (additive effects)

  • metoprolol
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    metoprolol
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + metoprolol

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of hypotension (additive effects)

  • milrinone
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    milrinone
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + milrinone

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of hypotension (additive effects)

  • milsaperidone
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    milsaperidone
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + milsaperidone

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may incr. risk of CNS depression, psychomotor impairment, hypotension, including orthostasis, syncope (additive effects)

  • minoxidil
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    minoxidil
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + minoxidil

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of hypotension (additive effects)

  • mirtazapine
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    mirtazapine
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + mirtazapine

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment, hypotension, including orthostasis (additive effects)

  • moexipril
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    moexipril
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + moexipril

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of hypotension (additive effects)

  • molindone
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    molindone
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + molindone

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment, hypotension, including orthostasis (additive effects)

  • morphine
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    morphine
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + morphine

    if elevated IOP or presbyopia use, monitor BP, respiratory rate; decrease dose of one or both drugs, use lowest effective doses and shortest duration of concomitant treatment; OTC ocular redness use OK: combo may increase risk of profound CNS and respiratory depression, psychomotor impairment, severe hypotension, including orthostasis, syncope (additive effects)

  • nadolol
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    nadolol
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + nadolol

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of hypotension (additive effects)

  • nalbuphine
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    nalbuphine
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + nalbuphine

    if elevated IOP or presbyopia use, monitor BP, respiratory rate; decrease dose of one or both drugs, use lowest effective doses and shortest duration of concomitant treatment; OTC ocular redness use OK: combo may increase risk of profound CNS and respiratory depression, psychomotor impairment, severe hypotension, including orthostasis, syncope (additive effects)

  • nattokinase
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    nattokinase
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + nattokinase

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of hypotension (additive effects)

  • naxitamab
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    naxitamab
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + naxitamab

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of hypotension, including orthostasis (additive effects)

  • nebivolol
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    nebivolol
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + nebivolol

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of hypotension (additive effects)

  • nelarabine
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    nelarabine
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + nelarabine

    caution advised if elevated IOP or presbyopia use; OTC ocular redness use OK; withhold nelarabine if Grade 2 or greater somnolence occurs: combo may increase risk of CNS depression, psychomotor impairment (additive effects)

  • niacin (vitamin B3)
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    niacin (vitamin B3)
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + niacin (vitamin B3)

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of hypotension, including orthostasis (additive effects)

  • nicardipine
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    nicardipine
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + nicardipine

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of hypotension (additive effects)

  • nifedipine
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    nifedipine
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + nifedipine

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of hypotension (additive effects)

  • nimodipine
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    nimodipine
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + nimodipine

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of hypotension (additive effects)

  • nisoldipine
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    nisoldipine
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + nisoldipine

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of hypotension (additive effects)

  • nitric oxide
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    nitric oxide
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + nitric oxide

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of hypotension (additive effects)

  • nitrite
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    nitrite
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + nitrite

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of severe or life-threatening hypotension, including syncope (additive effects)

  • nitroglycerin
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    nitroglycerin
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + nitroglycerin

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of severe hypotension, including orthostasis, syncope (additive effects)

  • nitroprusside
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    nitroprusside
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + nitroprusside

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of severe or life-threatening hypotension (additive effects)

  • nortriptyline
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    nortriptyline
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + nortriptyline

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment, hypotension, including orthostasis; may interfere with IOP lowering effect of brimonidine ophthalmic (additive effects; antagonistic effects)

  • obinutuzumab
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    obinutuzumab
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + obinutuzumab

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of hypotension (additive effects)

  • olanzapine
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    olanzapine
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + olanzapine

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment, hypotension, including orthostasis, syncope (additive effects)

  • oliceridine
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    oliceridine
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + oliceridine

    if elevated IOP or presbyopia use, monitor BP, respiratory rate; decrease dose of one or both drugs, use lowest effective doses and shortest duration of concomitant treatment; OTC ocular redness use OK: combo may increase risk of profound CNS and respiratory depression, psychomotor impairment, severe hypotension, including orthostasis, syncope (additive effects)

  • olmesartan medoxomil
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    olmesartan medoxomil
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + olmesartan medoxomil

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of hypotension (additive effects)

  • opicapone
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    opicapone
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + opicapone

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment, hypotension, including orthostasis, syncope (additive effects)

  • opium
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    opium
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + opium

    if elevated IOP or presbyopia use, monitor BP, respiratory rate; decrease dose of one or both drugs, use lowest effective doses and shortest duration of concomitant treatment; OTC ocular redness use OK: combo may increase risk of profound CNS and respiratory depression, psychomotor impairment, severe hypotension, including orthostasis, syncope (additive effects)

  • oxazepam
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    oxazepam
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + oxazepam

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS and respiratory depression, psychomotor impairment, hypotension (additive effects)

  • oxycodone
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    oxycodone
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + oxycodone

    if elevated IOP or presbyopia use, monitor BP, respiratory rate; decrease oxycodone start dose by at least 50%, use lowest effective doses and shortest duration of concomitant treatment; OTC ocular redness use OK: combo may increase risk of profound CNS and respiratory depression, psychomotor impairment, severe hypotension, including orthostasis, syncope (additive effects)

  • oxymorphone
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    oxymorphone
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + oxymorphone

    if elevated IOP or presbyopia use, monitor BP, respiratory rate; decrease oxymorphone start dose by at least 50%, use lowest effective doses and shortest duration of concomitant treatment; OTC ocular redness use OK: combo may increase risk of profound CNS and respiratory depression, psychomotor impairment, severe hypotension, including orthostasis, syncope (additive effects)

  • paliperidone
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    paliperidone
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + paliperidone

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment, hypotension, including orthostasis, syncope (additive effects)

  • palopegteriparatide
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    palopegteriparatide
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + palopegteriparatide

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of hypotension, including orthostasis, syncope (additive effects)

  • pentamidine
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    pentamidine
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + pentamidine

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of severe or life-threatening hypotension (additive effects)

  • pentazocine
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    pentazocine
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + pentazocine

    if elevated IOP or presbyopia use, monitor BP, respiratory rate; decrease dose of one or both drugs, use lowest effective doses and shortest duration of concomitant treatment; OTC ocular redness use OK: combo may increase risk of profound CNS and respiratory depression, psychomotor impairment, severe hypotension, including orthostasis, syncope (additive effects)

  • pentobarbital
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    pentobarbital
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + pentobarbital

    monitor BP, respiratory rate if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS and respiratory depression, psychomotor impairment, hypotension (additive effects)

  • perindopril
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    perindopril
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + perindopril

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of hypotension (additive effects)

  • perphenazine
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    perphenazine
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + perphenazine

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment, severe hypotension, including orthostasis, syncope (additive effects)

  • phenobarbital
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    phenobarbital
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + phenobarbital

    monitor BP, respiratory rate if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS and respiratory depression, psychomotor impairment, hypotension, including orthostasis (additive effects)

  • phenoxybenzamine
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    phenoxybenzamine
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + phenoxybenzamine

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of hypotension (additive effects)

  • phentolamine
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    phentolamine
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + phentolamine

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of hypotension (additive effects)

  • pindolol
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    pindolol
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + pindolol

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of hypotension (additive effects)

  • pramipexole
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    pramipexole
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + pramipexole

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment, hypotension, including orthostasis, syncope (additive effects)

  • prazosin
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    prazosin
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + prazosin

    monitor BP if elevated IOP or presbyopia use, especially during prazosin initiation/titration; OTC ocular redness use OK: combo may increase risk of hypotension, including orthostasis, syncope (additive effects)

  • primidone
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    primidone
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + primidone

    monitor respiratory rate if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS and respiratory depression, psychomotor impairment (additive effects)

  • procarbazine
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    procarbazine
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + procarbazine

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment, hypotension; may interfere with IOP lowering effect of brimonidine ophthalmic (additive effects; antagonistic effects)

  • prochlorperazine
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    prochlorperazine
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + prochlorperazine

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment, hypotension, including orthostasis (additive effects)

  • propafenone
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    propafenone
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + propafenone

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of hypotension (additive effects)

  • propofol
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    propofol
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + propofol

    monitor BP, respiratory rate if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS and respiratory depression, psychomotor impairment, severe hypotension (additive effects)

  • propranolol
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    propranolol
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + propranolol

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of hypotension (additive effects)

  • protriptyline
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    protriptyline
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + protriptyline

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment, hypotension, including orthostasis; may interfere with IOP lowering effect of brimonidine ophthalmic (additive effects; antagonistic effects)

  • quetiapine
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    quetiapine
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + quetiapine

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment, hypotension, including orthostasis, syncope (additive effects)

  • quinapril
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    quinapril
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + quinapril

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of hypotension (additive effects)

  • ramipril
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    ramipril
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + ramipril

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of hypotension (additive effects)

  • rasagiline
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    rasagiline
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + rasagiline

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment, hypotension, including orthostasis; may interfere with IOP lowering effect of brimonidine ophthalmic (additive effects; antagonistic effects)

  • remifentanil
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    remifentanil
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + remifentanil

    if elevated IOP or presbyopia use, monitor BP, respiratory rate; decrease dose of one or both drugs, use lowest effective doses and shortest duration of concomitant treatment; OTC ocular redness use OK: combo may increase risk of profound CNS and respiratory depression, psychomotor impairment, severe hypotension, including orthostasis, syncope (additive effects)

  • remimazolam
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    remimazolam
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + remimazolam

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of profound CNS and respiratory depression, psychomotor impairment, hypotension (additive effects)

  • riociguat
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    riociguat
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + riociguat

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of severe hypotension (additive effects)

  • risperidone
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    risperidone
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + risperidone

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment, hypotension, including orthostasis, syncope (additive effects)

  • ropinirole
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    ropinirole
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + ropinirole

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment, hypotension, including orthostasis, syncope (additive effects)

  • ropivacaine
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    ropivacaine
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + ropivacaine

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of hypotension (additive effects)

  • rotigotine transdermal
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    rotigotine transdermal
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + rotigotine transdermal

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment, severe hypotension, including orthostasis, syncope (additive effects)

  • sacubitril
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    sacubitril
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + sacubitril

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of hypotension, including orthostasis (additive effects)

  • safinamide
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    safinamide
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + safinamide

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment, hypotension, including orthostasis; may interfere with IOP lowering effect of brimonidine ophthalmic (additive effects; antagonistic effects)

  • selegiline
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    selegiline
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + selegiline

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment, hypotension including orthostasis; may interfere with IOP lowering effect of brimonidine ophthalmic (additive effects; antagonistic effects)

  • selegiline transdermal
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    selegiline transdermal
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + selegiline transdermal

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment, hypotension, including orthostasis; may interfere with IOP lowering effect of brimonidine ophthalmic (additive effects; antagonistic effects)

  • sevoflurane
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    sevoflurane
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + sevoflurane

    monitor BP, respiratory rate if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS and respiratory depression, psychomotor impairment, hypotension (additive effects)

  • sildenafil
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    sildenafil
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + sildenafil

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of hypotension (additive effects)

  • silodosin
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    silodosin
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + silodosin

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of hypotension, including orthostasis, syncope (additive effects)

  • sodium ferric gluconate complex
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    sodium ferric gluconate complex
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + sodium ferric gluconate complex

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of hypotension (additive effects)

  • sotagliflozin
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    sotagliflozin
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + sotagliflozin

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of hypotension, including orthostasis (additive effects)

  • sotalol
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    sotalol
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + sotalol

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of hypotension (additive effects)

  • sparsentan
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    sparsentan
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + sparsentan

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of hypotension, including orthostasis, syncope (additive effects)

  • spironolactone
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    spironolactone
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + spironolactone

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of hypotension (additive effects)

  • sufentanil
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    sufentanil
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + sufentanil

    if elevated IOP or presbyopia use, monitor BP, respiratory rate; decrease sufentanil start dose, use lowest effective doses; OTC ocular redness use OK: combo may increase risk of profound CNS and respiratory depression, psychomotor impairment, severe hypotension, including orthostasis, syncope (additive effects)

  • tadalafil
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    tadalafil
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + tadalafil

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of hypotension (additive effects)

  • tagraxofusp
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    tagraxofusp
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + tagraxofusp

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of hypotension (additive effects)

  • tamsulosin
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    tamsulosin
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + tamsulosin

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of hypotension, including orthostasis, syncope (additive effects)

  • tapentadol
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    tapentadol
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + tapentadol

    if elevated IOP or presbyopia use, monitor BP, respiratory rate; decrease dose of one or both drugs, use lowest effective doses and shortest duration of concomitant treatment; OTC ocular redness use OK: combo may increase risk of profound CNS and respiratory depression, psychomotor impairment, severe hypotension, including orthostasis, syncope (additive effects)

  • taurine
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    taurine
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + taurine

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of hypotension (additive effects)

  • telmisartan
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    telmisartan
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + telmisartan

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of hypotension (additive effects)

  • terazosin
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    terazosin
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + terazosin

    monitor BP if elevated IOP or presbyopia use, especially during terazosin initiation/titration; OTC ocular redness use OK: combo may increase risk of hypotension, including orthostasis, syncope (additive effects)

  • thalidomide
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    thalidomide
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + thalidomide

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment, hypotension, including orthostasis (additive effects)

  • thioridazine
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    thioridazine
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + thioridazine

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment, hypotension, including orthostasis (additive effects)

  • thiothixene
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    thiothixene
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + thiothixene

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment, hypotension, including syncope (additive effects)

  • timolol
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    timolol
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + timolol

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of hypotension (additive effects)

  • timolol ophthalmic
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    timolol ophthalmic
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + timolol ophthalmic

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of hypotension (additive effects)

  • tizanidine
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    tizanidine
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + tizanidine

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment, hypotension, including orthostasis, syncope (additive effects)

  • tolcapone
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    tolcapone
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + tolcapone

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment, hypotension, including orthostasis, syncope (additive effects)

  • torsemide
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    torsemide
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + torsemide

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of hypotension (additive effects)

  • tramadol
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    tramadol
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + tramadol

    if elevated IOP or presbyopia use, monitor BP, respiratory rate; decrease dose of one or both drugs, use lowest effective doses and shortest duration of concomitant treatment; OTC ocular redness use OK: combo may increase risk of profound CNS and respiratory depression, psychomotor impairment, severe hypotension, including orthostasis, syncope (additive effects)

  • trandolapril
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    trandolapril
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + trandolapril

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of hypotension (additive effects)

  • trazodone
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    trazodone
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + trazodone

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment, hypotension, including orthostasis, syncope (additive effects)

  • treprostinil
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    treprostinil
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + treprostinil

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of severe hypotension, including syncope (additive effects)

  • triamterene
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    triamterene
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + triamterene

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of hypotension (additive effects)

  • trifluoperazine
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    trifluoperazine
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + trifluoperazine

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment, severe hypotension, including orthostasis (additive effects)

  • trimipramine
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    trimipramine
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + trimipramine

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment, hypotension, including orthostasis; may interfere with IOP lowering effect of brimonidine ophthalmic (additive effects; antagonistic effects)

  • valsartan
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    valsartan
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + valsartan

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of hypotension (additive effects)

  • vardenafil
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    vardenafil
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + vardenafil

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of hypotension (additive effects)

  • verapamil
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    verapamil
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + verapamil

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of hypotension (additive effects)

  • vosoritide
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    vosoritide
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + vosoritide

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of hypotension (additive effects)

  • yohimbe
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    yohimbe
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + yohimbe

    monitor BP if elevated IOP or presbyopia use, especially with high yohimbe doses; OTC ocular redness use OK: combo may increase risk of hypotension (additive effects)

  • ziprasidone
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    ziprasidone
    1 interaction

    Monitor/Modify Tx

    brimonidine ophthalmic + ziprasidone

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment, hypotension, including orthostasis, syncope (additive effects)

Caution Advised

  • 5-HTP
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    5-HTP
    1 interaction

    Caution Advised

    brimonidine ophthalmic + 5-HTP

    caution advised if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment (additive effects)

  • allopurinol
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    allopurinol
    1 interaction

    Caution Advised

    brimonidine ophthalmic + allopurinol

    caution advised if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment (additive effects)

  • almotriptan
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    almotriptan
    1 interaction

    Caution Advised

    brimonidine ophthalmic + almotriptan

    caution advised if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment (additive effects)

  • alprazolam
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    alprazolam
    1 interaction

    Caution Advised

    brimonidine ophthalmic + alprazolam

    caution advised if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS and respiratory depression, psychomotor impairment (additive effects)

  • atropine ophthalmic
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    atropine ophthalmic
    1 interaction

    Caution Advised

    carbachol ophthalmic + atropine ophthalmic

    caution advised: combo may decr. efficacy of both drugs (antagonistic effects)

  • baclofen
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    baclofen
    1 interaction

    Caution Advised

    brimonidine ophthalmic + baclofen

    caution advised if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment (additive effects)

  • baclofen intrathecal
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    baclofen intrathecal
    1 interaction

    Caution Advised

    brimonidine ophthalmic + baclofen intrathecal

    caution advised if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS and respiratory depression, psychomotor impairment (additive effects)

  • brivaracetam
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    brivaracetam
    1 interaction

    Caution Advised

    brimonidine ophthalmic + brivaracetam

    caution advised if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment (additive effects)

  • bromfenac ophthalmic
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    bromfenac ophthalmic
    1 interaction

    Caution Advised

    carbachol ophthalmic + bromfenac ophthalmic

    caution advised: combo may decr. carbachol efficacy (antagonistic effects)

  • brompheniramine
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    brompheniramine
    1 interaction

    Caution Advised

    brimonidine ophthalmic + brompheniramine

    caution advised if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment (additive effects)

  • buspirone
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    buspirone
    1 interaction

    Caution Advised

    brimonidine ophthalmic + buspirone

    caution advised if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment (additive effects)

  • cannabidiol
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    cannabidiol
    1 interaction

    Caution Advised

    brimonidine ophthalmic + cannabidiol

    caution advised if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment (additive effects)

  • carbinoxamine
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    carbinoxamine
    1 interaction

    Caution Advised

    brimonidine ophthalmic + carbinoxamine

    caution advised if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment (additive effects)

  • carisoprodol
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    carisoprodol
    1 interaction

    Caution Advised

    brimonidine ophthalmic + carisoprodol

    caution advised if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment (additive effects)

  • cenobamate
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    cenobamate
    1 interaction

    Caution Advised

    brimonidine ophthalmic + cenobamate

    caution advised if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment (additive effects)

  • cetirizine
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    cetirizine
    1 interaction

    Caution Advised

    brimonidine ophthalmic + cetirizine

    caution advised if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment (additive effects)

  • chamomile, German
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    chamomile, German
    1 interaction

    Caution Advised

    brimonidine ophthalmic + chamomile, German

    caution advised if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment (additive effects)

  • chlophedianol
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    chlophedianol
    1 interaction

    Caution Advised

    brimonidine ophthalmic + chlophedianol

    caution advised if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment (additive effects)

  • chlorcyclizine
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    chlorcyclizine
    1 interaction

    Caution Advised

    brimonidine ophthalmic + chlorcyclizine

    caution advised if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment (additive effects)

  • chlordiazepoxide
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    chlordiazepoxide
    1 interaction

    Caution Advised

    brimonidine ophthalmic + chlordiazepoxide

    caution advised if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS and respiratory depression, psychomotor impairment (additive effects)

  • chlorpheniramine
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    chlorpheniramine
    1 interaction

    Caution Advised

    brimonidine ophthalmic + chlorpheniramine

    caution advised if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment (additive effects)

  • chlorzoxazone
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    chlorzoxazone
    1 interaction

    Caution Advised

    brimonidine ophthalmic + chlorzoxazone

    caution advised if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment (additive effects)

  • citalopram
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    citalopram
    1 interaction

    Caution Advised

    brimonidine ophthalmic + citalopram

    caution advised if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment (additive effects)

  • clemastine
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    clemastine
    1 interaction

    Caution Advised

    brimonidine ophthalmic + clemastine

    caution advised if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment (additive effects)

  • clobazam
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    clobazam
    1 interaction

    Caution Advised

    brimonidine ophthalmic + clobazam

    caution advised if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS and respiratory depression, psychomotor impairment (additive effects)

  • clonazepam
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    clonazepam
    1 interaction

    Caution Advised

    brimonidine ophthalmic + clonazepam

    caution advised if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS and respiratory depression, psychomotor impairment (additive effects)

  • clorazepate
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    clorazepate
    1 interaction

    Caution Advised

    brimonidine ophthalmic + clorazepate

    caution advised if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS and respiratory depression, psychomotor impairment (additive effects)

  • cyclobenzaprine
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    cyclobenzaprine
    1 interaction

    Caution Advised

    brimonidine ophthalmic + cyclobenzaprine

    caution advised if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment (additive effects)

  • cyclopentolate ophthalmic
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    cyclopentolate ophthalmic
    1 interaction

    Caution Advised

    carbachol ophthalmic + cyclopentolate ophthalmic

    caution advised: combo may decr. efficacy of both drugs (antagonistic effects)

  • cyproheptadine
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    cyproheptadine
    1 interaction

    Caution Advised

    brimonidine ophthalmic + cyproheptadine

    caution advised if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment (additive effects)

  • dantrolene
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    dantrolene
    1 interaction

    Caution Advised

    brimonidine ophthalmic + dantrolene

    caution advised if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment (additive effects)

  • daridorexant
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    daridorexant
    1 interaction

    Caution Advised

    brimonidine ophthalmic + daridorexant

    caution advised if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment (additive effects)

  • darifenacin
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    darifenacin
    1 interaction

    Caution Advised

    brimonidine ophthalmic + darifenacin

    caution advised if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment (additive effects)

  • desvenlafaxine
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    desvenlafaxine
    1 interaction

    Caution Advised

    brimonidine ophthalmic + desvenlafaxine

    caution advised if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment (additive effects)

  • deutetrabenazine
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    deutetrabenazine
    1 interaction

    Caution Advised

    brimonidine ophthalmic + deutetrabenazine

    caution advised if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment (additive effects)

  • dexbrompheniramine
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    dexbrompheniramine
    1 interaction

    Caution Advised

    brimonidine ophthalmic + dexbrompheniramine

    caution advised if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment (additive effects)

  • dexchlorpheniramine
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    dexchlorpheniramine
    1 interaction

    Caution Advised

    brimonidine ophthalmic + dexchlorpheniramine

    caution advised if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment (additive effects)

  • diazepam
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    diazepam
    1 interaction

    Caution Advised

    brimonidine ophthalmic + diazepam

    caution advised if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of profound CNS and respiratory depression, psychomotor impairment (additive effects)

  • dichlorphenamide
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    dichlorphenamide
    1 interaction

    Caution Advised

    brimonidine ophthalmic + dichlorphenamide

    caution advised if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment (additive effects)

  • diclofenac ophthalmic
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    diclofenac ophthalmic
    1 interaction

    Caution Advised

    carbachol ophthalmic + diclofenac ophthalmic

    caution advised: combo may decr. carbachol efficacy (antagonistic effects)

  • difelikefalin
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    difelikefalin
    1 interaction

    Caution Advised

    brimonidine ophthalmic + difelikefalin

    caution advised if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment (additive effects)

  • difenoxin
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    difenoxin
    1 interaction

    Caution Advised

    brimonidine ophthalmic + difenoxin

    caution advised if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment (additive effects)

  • dimenhydrinate
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    dimenhydrinate
    1 interaction

    Caution Advised

    brimonidine ophthalmic + dimenhydrinate

    caution advised if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment (additive effects)

  • diphenhydramine
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    diphenhydramine
    1 interaction

    Caution Advised

    brimonidine ophthalmic + diphenhydramine

    caution advised if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment (additive effects)

  • diphenoxylate
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    diphenoxylate
    1 interaction

    Caution Advised

    brimonidine ophthalmic + diphenoxylate

    caution advised if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment (additive effects)

  • domperidone
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    domperidone
    1 interaction

    Caution Advised

    brimonidine ophthalmic + domperidone

    caution advised if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment (additive effects)

  • doxepin topical
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    doxepin topical
    1 interaction

    Caution Advised

    brimonidine ophthalmic + doxepin topical

    caution advised if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment (additive effects)

  • droperidol
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    droperidol
    1 interaction

    Caution Advised

    brimonidine ophthalmic + droperidol

    caution advised if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment (additive effects)

  • efavirenz
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    efavirenz
    1 interaction

    Caution Advised

    brimonidine ophthalmic + efavirenz

    caution advised if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment (additive effects)

  • eletriptan
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    eletriptan
    1 interaction

    Caution Advised

    brimonidine ophthalmic + eletriptan

    caution advised if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment (additive effects)

  • elinzanetant
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    elinzanetant
    1 interaction

    Caution Advised

    brimonidine ophthalmic + elinzanetant

    caution advised if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment (additive effects)

  • escitalopram
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    escitalopram
    1 interaction

    Caution Advised

    brimonidine ophthalmic + escitalopram

    caution advised if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment (additive effects)

  • eslicarbazepine acetate
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    eslicarbazepine acetate
    1 interaction

    Caution Advised

    brimonidine ophthalmic + eslicarbazepine acetate

    caution advised if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment (additive effects)

  • estazolam
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    estazolam
    1 interaction

    Caution Advised

    brimonidine ophthalmic + estazolam

    caution advised if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS and respiratory depression, psychomotor impairment (additive effects)

  • eszopiclone
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    eszopiclone
    1 interaction

    Caution Advised

    brimonidine ophthalmic + eszopiclone

    caution advised if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment (additive effects)

  • ethosuximide
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    ethosuximide
    1 interaction

    Caution Advised

    brimonidine ophthalmic + ethosuximide

    caution advised if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment (additive effects)

  • felbamate
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    felbamate
    1 interaction

    Caution Advised

    brimonidine ophthalmic + felbamate

    caution advised if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment (additive effects)

  • fenfluramine
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    fenfluramine
    1 interaction

    Caution Advised

    brimonidine ophthalmic + fenfluramine

    caution advised if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment (additive effects)

  • fesoterodine
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    fesoterodine
    1 interaction

    Caution Advised

    brimonidine ophthalmic + fesoterodine

    caution advised if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment (additive effects)

  • fluoxetine
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    fluoxetine
    1 interaction

    Caution Advised

    brimonidine ophthalmic + fluoxetine

    caution advised if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment (additive effects)

  • flurazepam
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    flurazepam
    1 interaction

    Caution Advised

    brimonidine ophthalmic + flurazepam

    caution advised if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS and respiratory depression, psychomotor impairment (additive effects)

  • flurbiprofen ophthalmic
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    flurbiprofen ophthalmic
    1 interaction

    Caution Advised

    carbachol ophthalmic + flurbiprofen ophthalmic

    caution advised: combo may decr. carbachol efficacy (antagonistic effects)

  • fluvoxamine
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    fluvoxamine
    1 interaction

    Caution Advised

    brimonidine ophthalmic + fluvoxamine

    caution advised if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment (additive effects)

  • fosphenytoin
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    fosphenytoin
    1 interaction

    Caution Advised

    brimonidine ophthalmic + fosphenytoin

    caution advised if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment (additive effects)

  • frovatriptan
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    frovatriptan
    1 interaction

    Caution Advised

    brimonidine ophthalmic + frovatriptan

    caution advised if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment (additive effects)

  • gabapentin
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    gabapentin
    1 interaction

    Caution Advised

    brimonidine ophthalmic + gabapentin

    caution advised if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of profound CNS and respiratory depression, psychomotor impairment (additive effects)

  • gabapentin enacarbil
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    gabapentin enacarbil
    1 interaction

    Caution Advised

    brimonidine ophthalmic + gabapentin enacarbil

    caution advised if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of profound CNS and respiratory depression, psychomotor impairment (additive effects)

  • ganaxolone
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    ganaxolone
    1 interaction

    Caution Advised

    brimonidine ophthalmic + ganaxolone

    caution advised if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment (additive effects)

  • glofitamab
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    glofitamab
    1 interaction

    Caution Advised

    brimonidine ophthalmic + glofitamab

    caution advised if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment (additive effects)

  • glycopyrrolate
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    glycopyrrolate
    1 interaction

    Caution Advised

    brimonidine ophthalmic + glycopyrrolate

    caution advised if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment (additive effects)

  • hydroxyzine
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    hydroxyzine
    1 interaction

    Caution Advised

    brimonidine ophthalmic + hydroxyzine

    caution advised if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment (additive effects)

  • hyoscyamine
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    hyoscyamine
    1 interaction

    Caution Advised

    brimonidine ophthalmic + hyoscyamine

    caution advised if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment (additive effects)

  • kava
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    kava
    1 interaction

    Caution Advised

    brimonidine ophthalmic + kava

    caution advised if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment (additive effects)

  • ketorolac ophthalmic
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    ketorolac ophthalmic
    1 interaction

    Caution Advised

    carbachol ophthalmic + ketorolac ophthalmic

    caution advised: combo may decr. carbachol efficacy (antagonistic effects)

  • lacosamide
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    lacosamide
    1 interaction

    Caution Advised

    brimonidine ophthalmic + lacosamide

    caution advised if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment (additive effects)

  • lamotrigine
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    lamotrigine
    1 interaction

    Caution Advised

    brimonidine ophthalmic + lamotrigine

    caution advised if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment (additive effects)

  • lemborexant
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    lemborexant
    1 interaction

    Caution Advised

    brimonidine ophthalmic + lemborexant

    caution advised if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment (additive effects)

  • levetiracetam
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    levetiracetam
    1 interaction

    Caution Advised

    brimonidine ophthalmic + levetiracetam

    caution advised if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment (additive effects)

  • levocetirizine
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    levocetirizine
    1 interaction

    Caution Advised

    brimonidine ophthalmic + levocetirizine

    caution advised if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment (additive effects)

  • levomilnacipran
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    levomilnacipran
    1 interaction

    Caution Advised

    brimonidine ophthalmic + levomilnacipran

    caution advised if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment (additive effects)

  • linezolid
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    linezolid
    1 interaction

    Caution Advised

    brimonidine ophthalmic + linezolid

    caution advised if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may interfere with IOP lowering effect of brimonidine ophthalmic (antagonistic effects)

  • linvoseltamab
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    linvoseltamab
    1 interaction

    Caution Advised

    brimonidine ophthalmic + linvoseltamab

    caution advised if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment (additive effects)

  • lorazepam
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    lorazepam
    1 interaction

    Caution Advised

    brimonidine ophthalmic + lorazepam

    caution advised if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of profound CNS and respiratory depression, psychomotor impairment (additive effects)

  • meclizine
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    meclizine
    1 interaction

    Caution Advised

    brimonidine ophthalmic + meclizine

    caution advised if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment (additive effects)

  • melatonin
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    melatonin
    1 interaction

    Caution Advised

    brimonidine ophthalmic + melatonin

    caution advised if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment (additive effects)

  • meprobamate
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    meprobamate
    1 interaction

    Caution Advised

    brimonidine ophthalmic + meprobamate

    caution advised if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment (additive effects)

  • methocarbamol
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    methocarbamol
    1 interaction

    Caution Advised

    brimonidine ophthalmic + methocarbamol

    caution advised if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment (additive effects)

  • methsuximide
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    methsuximide
    1 interaction

    Caution Advised

    brimonidine ophthalmic + methsuximide

    caution advised if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment (additive effects)

  • metyrapone
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    metyrapone
    1 interaction

    Caution Advised

    brimonidine ophthalmic + metyrapone

    caution advised if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment (additive effects)

  • metyrosine
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    metyrosine
    1 interaction

    Caution Advised

    brimonidine ophthalmic + metyrosine

    caution advised if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment (additive effects)

  • milnacipran
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    milnacipran
    1 interaction

    Caution Advised

    brimonidine ophthalmic + milnacipran

    caution advised if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment (additive effects)

  • mitotane
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    mitotane
    1 interaction

    Caution Advised

    brimonidine ophthalmic + mitotane

    caution advised if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment (additive effects)

  • mosunetuzumab
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    mosunetuzumab
    1 interaction

    Caution Advised

    brimonidine ophthalmic + mosunetuzumab

    caution advised if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment (additive effects)

  • mycophenolate mofetil
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    mycophenolate mofetil
    1 interaction

    Caution Advised

    brimonidine ophthalmic + mycophenolate mofetil

    caution advised if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment (additive effects)

  • naltrexone
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    naltrexone
    1 interaction

    Caution Advised

    brimonidine ophthalmic + naltrexone

    caution advised if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment (additive effects)

  • naratriptan
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    naratriptan
    1 interaction

    Caution Advised

    brimonidine ophthalmic + naratriptan

    caution advised if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment (additive effects)

  • nefazodone
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    nefazodone
    1 interaction

    Caution Advised

    brimonidine ophthalmic + nefazodone

    caution advised if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment (additive effects)

  • nepafenac ophthalmic
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    nepafenac ophthalmic
    1 interaction

    Caution Advised

    carbachol ophthalmic + nepafenac ophthalmic

    caution advised: combo may decr. carbachol efficacy (antagonistic effects)

  • orphenadrine
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    orphenadrine
    1 interaction

    Caution Advised

    brimonidine ophthalmic + orphenadrine

    caution advised if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment (additive effects)

  • oxcarbazepine
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    oxcarbazepine
    1 interaction

    Caution Advised

    brimonidine ophthalmic + oxcarbazepine

    caution advised if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment (additive effects)

  • oxybate
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    oxybate
    1 interaction

    Caution Advised

    brimonidine ophthalmic + oxybate

    caution advised if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of profound CNS and respiratory depression, psychomotor impairment, hypotension, syncope (additive effects)

  • oxybutynin
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    oxybutynin
    1 interaction

    Caution Advised

    brimonidine ophthalmic + oxybutynin

    caution advised or consider oxybutynin transdermal patch if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment; somnolence less likely with oxybutynin transdermal patch (additive effects)

  • paroxetine
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    paroxetine
    1 interaction

    Caution Advised

    brimonidine ophthalmic + paroxetine

    caution advised if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment (additive effects)

  • passion flower
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    passion flower
    1 interaction

    Caution Advised

    brimonidine ophthalmic + passion flower

    caution advised if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment (additive effects)

  • perampanel
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    perampanel
    1 interaction

    Caution Advised

    brimonidine ophthalmic + perampanel

    caution advised if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment (additive effects)

  • pheniramine
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    pheniramine
    1 interaction

    Caution Advised

    brimonidine ophthalmic + pheniramine

    caution advised if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment (additive effects)

  • phenytoin
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    phenytoin
    1 interaction

    Caution Advised

    brimonidine ophthalmic + phenytoin

    caution advised if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment (additive effects)

  • pimozide
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    pimozide
    1 interaction

    Caution Advised

    brimonidine ophthalmic + pimozide

    caution advised if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment (additive effects)

  • pregabalin
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    pregabalin
    1 interaction

    Caution Advised

    brimonidine ophthalmic + pregabalin

    caution advised if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of profound CNS and respiratory depression, psychomotor impairment (additive effects)

  • pyrilamine
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    pyrilamine
    1 interaction

    Caution Advised

    brimonidine ophthalmic + pyrilamine

    caution advised if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment (additive effects)

  • quazepam
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    quazepam
    1 interaction

    Caution Advised

    brimonidine ophthalmic + quazepam

    caution advised if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS and respiratory depression, psychomotor impairment (additive effects)

  • ramelteon
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    ramelteon
    1 interaction

    Caution Advised

    brimonidine ophthalmic + ramelteon

    caution advised if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment (additive effects)

  • repotrectinib
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    repotrectinib
    1 interaction

    Caution Advised

    brimonidine ophthalmic + repotrectinib

    caution advised if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment (additive effects)

  • rizatriptan
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    rizatriptan
    1 interaction

    Caution Advised

    brimonidine ophthalmic + rizatriptan

    caution advised if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment (additive effects)

  • rufinamide
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    rufinamide
    1 interaction

    Caution Advised

    brimonidine ophthalmic + rufinamide

    caution advised if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment (additive effects)

  • selinexor
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    selinexor
    1 interaction

    Caution Advised

    brimonidine ophthalmic + selinexor

    caution advised if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment (additive effects)

  • sertraline
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    sertraline
    1 interaction

    Caution Advised

    brimonidine ophthalmic + sertraline

    caution advised if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment (additive effects)

  • solifenacin
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    solifenacin
    1 interaction

    Caution Advised

    brimonidine ophthalmic + solifenacin

    caution advised if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment (additive effects)

  • stiripentol
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    stiripentol
    1 interaction

    Caution Advised

    brimonidine ophthalmic + stiripentol

    caution advised if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment (additive effects)

  • sumatriptan
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    sumatriptan
    1 interaction

    Caution Advised

    brimonidine ophthalmic + sumatriptan

    caution advised if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment (additive effects)

  • suvorexant
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    suvorexant
    1 interaction

    Caution Advised

    brimonidine ophthalmic + suvorexant

    caution advised if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment (additive effects)

  • tasimelteon
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    tasimelteon
    1 interaction

    Caution Advised

    brimonidine ophthalmic + tasimelteon

    caution advised if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment (additive effects)

  • temazepam
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    temazepam
    1 interaction

    Caution Advised

    brimonidine ophthalmic + temazepam

    caution advised if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS and respiratory depression, psychomotor impairment (additive effects)

  • tetrabenazine
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    tetrabenazine
    1 interaction

    Caution Advised

    brimonidine ophthalmic + tetrabenazine

    caution advised if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment (additive effects)

  • thiotepa
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    thiotepa
    1 interaction

    Caution Advised

    brimonidine ophthalmic + thiotepa

    caution advised if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment (additive effects)

  • tiagabine
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    tiagabine
    1 interaction

    Caution Advised

    brimonidine ophthalmic + tiagabine

    caution advised if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment (additive effects)

  • tolterodine
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    tolterodine
    1 interaction

    Caution Advised

    brimonidine ophthalmic + tolterodine

    caution advised if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment (additive effects)

  • topiramate
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    topiramate
    1 interaction

    Caution Advised

    brimonidine ophthalmic + topiramate

    caution advised if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment (additive effects)

  • triazolam
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    triazolam
    1 interaction

    Caution Advised

    brimonidine ophthalmic + triazolam

    caution advised if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS and respiratory depression, psychomotor impairment (additive effects)

  • trihexyphenidyl
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    trihexyphenidyl
    1 interaction

    Caution Advised

    brimonidine ophthalmic + trihexyphenidyl

    caution advised if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment (additive effects)

  • trimethobenzamide
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    trimethobenzamide
    1 interaction

    Caution Advised

    brimonidine ophthalmic + trimethobenzamide

    caution advised if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment (additive effects)

  • triprolidine
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    triprolidine
    1 interaction

    Caution Advised

    brimonidine ophthalmic + triprolidine

    caution advised if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment (additive effects)

  • tropicamide ophthalmic
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    tropicamide ophthalmic
    1 interaction

    Caution Advised

    carbachol ophthalmic + tropicamide ophthalmic

    caution advised: combo may decr. efficacy of both drugs (antagonistic effects)

  • trospium
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    trospium
    1 interaction

    Caution Advised

    brimonidine ophthalmic + trospium

    caution advised if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment (additive effects)

  • valbenazine
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    valbenazine
    1 interaction

    Caution Advised

    brimonidine ophthalmic + valbenazine

    caution advised if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment (additive effects)

  • valerian
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    valerian
    1 interaction

    Caution Advised

    brimonidine ophthalmic + valerian

    caution advised if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment (additive effects)

  • valproic acid
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    valproic acid
    1 interaction

    Caution Advised

    brimonidine ophthalmic + valproic acid

    caution advised if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment (additive effects)

  • venlafaxine
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    venlafaxine
    1 interaction

    Caution Advised

    brimonidine ophthalmic + venlafaxine

    caution advised if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment (additive effects)

  • vigabatrin
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    vigabatrin
    1 interaction

    Caution Advised

    brimonidine ophthalmic + vigabatrin

    caution advised if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment (additive effects)

  • vilazodone
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    vilazodone
    1 interaction

    Caution Advised

    brimonidine ophthalmic + vilazodone

    caution advised if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment (additive effects)

  • viloxazine
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    viloxazine
    1 interaction

    Caution Advised

    brimonidine ophthalmic + viloxazine

    caution advised if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment (additive effects)

  • zaleplon
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    zaleplon
    1 interaction

    Caution Advised

    brimonidine ophthalmic + zaleplon

    caution advised if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment (additive effects)

  • ziconotide
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    ziconotide
    1 interaction

    Caution Advised

    brimonidine ophthalmic + ziconotide

    caution advised if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment (additive effects)

  • zolmitriptan
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    zolmitriptan
    1 interaction

    Caution Advised

    brimonidine ophthalmic + zolmitriptan

    caution advised if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment (additive effects)

  • zolpidem
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    zolpidem
    1 interaction

    Caution Advised

    brimonidine ophthalmic + zolpidem

    caution advised if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment (additive effects)

  • zonisamide
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    zonisamide
    1 interaction

    Caution Advised

    brimonidine ophthalmic + zonisamide

    caution advised if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment (additive effects)

  • zuranolone
  • Yuvezzi (carbachol/ brimonidine ophthalmic)
    +
    zuranolone
    1 interaction

    Caution Advised

    brimonidine ophthalmic + zuranolone

    caution advised if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment (additive effects)

Adverse Reactions .

Serious Reactions

    com.epocrates.rxweb.beans.StringCollection@7a855208
  • hypersensitivity reaction
  • retinal tear
  • retinal detachment
  • iritis
  • vascular insufficiency

Common Reactions

    com.epocrates.rxweb.beans.StringCollection@883d890
  • ocular irritation
  • headache
  • ocular pain
  • visual impairment

Safety/Monitoring .

Monitoring Parameters
retinal exam at baseline

Pregnancy/Lactation .

Pregnancy

Clinical Summary

may use during pregnancy; no human data available, though risk of fetal harm not expected based on limited systemic absorption

Lactation

may use while breastfeeding; no human data available, though risk of infant harm and adverse effects on milk production not expected based on limited systemic absorption in breastfeeding patients

Pharmacology .

com.epocrates.rxweb.beans.DrugOtherInfoBean@54b2c2cf

Metabolism: for carbachol: unknown; CYP450: unknown; for brimonidine: liver primarily; CYP450: unknown; Info: limited systemic absorption

Excretion: for carbachol: unknown; Half-life: unknown; for brimonidine: urine 74%; Half-life: 2h

Subclass: Cholinergics/Miotics

Mechanism of Action
for carbachol: stimulates cholinergic receptors, reducing pupil size to improve near visual acuity; for brimonidine: stimulates alpha-2 adrenergic receptors, inhibiting iris dilator and ciliary muscle contraction

Formulary .

No Formulary Selected

Manufacturer/Pricing .

Manufacturer: Tenpoint Therapeutics, Ltd.

com.epocrates.rxweb.beans.DrugOtherInfoBean@5526272

DEA/FDA: Rx

Retail Price

This information is currently not available for this drug.

Join Now to View Patient Handouts!

Create a FREE epocrates Online account to access patient medication instructions. Your patients and caregivers will appreciate you printing these friendly handouts, available in English and Spanish. Each handout addresses common concerns such as how to take the medication, and possible side effects.

Current Members: Sign In.

Sign Up Now - It's Free >>

Pill Pictures

Join Now to View Pill Pictures!

Create a FREE epocrates Online account to access full-color images of medications within the drug monograph.

Current Members: Sign In.

Sign Up Now - It's Free >>

Help
FDA Reporting Form
 
Download Epocrates from the App Store Download Epocrates from the Play Store
About Us Features Business Solutions Help & Feedback
© 2026 epocrates, Inc.    Terms of Use Privacy Policy Editorial Policy Do Not Sell or Share My Information